Chordin (encoded by CHRD) has been identified as a negative prognostic factor in CRC and several other cancers, including lung, cervical, urothelial, renal, and stomach cancers, and is correlated with significantly lower survivability [64, 66]. Here, CHRD is linked to gastric neoplasm.